We chose huntingtin (9.4 kb) and dystrophin (11 kb) as target transgenes, as it is very difficult for other viral vectors to deliver these large genes and gene therapy has long been pursued as a treatment option for the associated diseases (HD and DMD). This evidence concerns the gene HTT and Duchenne muscular dystrophy.